AN2 Therapeutics reported raising $40 Million in an initial SEC Form D filing, from an offering of $40 Million
Round Type
Post-IPO Equity
Menlo ParkBiotechnologyHealth CareScience And EngineeringInvestors
Description
AN2 Therapeutics, Inc. announces a $40 million private placement financing, involving the sale of over 8 million shares. The placement aims to fund the company's novel small molecule therapeutics development. It is anticipated to close on March 10, 2026, subject to conditions
Quick answer
AN2 Therapeutics raised $40 Million in a Post-IPO Equity round, dated March 10, 2026. Investors: Vivo Capital, Commodore Capital and Coastlands Capital. AN2 Therapeutics is based in Menlo Park, California, United States.
- How much did AN2 Therapeutics raise?
- AN2 Therapeutics raised $40 Million in a Post-IPO Equity round on March 10, 2026.
- Who invested in AN2 Therapeutics?
- Vivo Capital, Commodore Capital and Coastlands Capital are named as investors in this round.
- What does AN2 Therapeutics do?
- AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform.
- Where is AN2 Therapeutics based and how big is it?
- AN2 Therapeutics is based in Menlo Park, California, United States. Fundz records about 36 employees.
- Who are the decision-makers at AN2 Therapeutics?
- Fundz holds 1 contact at AN2 Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as AN2 Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Maze Therapeutics raised $145M (Post-IPO Equity) on April 22, 2026.
- Ray Therapeutics raised $125M (Series B) on April 21, 2026.
- Orthogon Therapeutics raised $11M (Funding Round) on April 17, 2026.
- Enveric Biosciences raised $5M on April 17, 2026.
- Athos Therapeutics, Inc. raised $10M on April 17, 2026.
- Bond Biosciences raised $5.3M on April 1, 2026.
Who to call at AN2 Therapeutics, and when
A new round usually means AN2 Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AN2 Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AN2 Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AN2 Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AN2 Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
AN2 Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.